[Fertility preservation and access to medically assisted reproduction for Trans people: Guidelines from French Professional Association for Transgender Health].

Préservation de la fertilité et accès à l’assistance médicale à la procréation chez les personnes Trans : recommandations de Trans Santé France.
Assistance médicale à la procréation Assisted Reproduction Technology Fertility preservation Loi de bioéthique Préservation de la fertilité Transgender Transgenre Transidentity Transidentité

Journal

Gynecologie, obstetrique, fertilite & senologie
ISSN: 2468-7189
Titre abrégé: Gynecol Obstet Fertil Senol
Pays: France
ID NLM: 101693805

Informations de publication

Date de publication:
10 2022
Historique:
received: 07 02 2022
revised: 13 06 2022
accepted: 15 06 2022
pubmed: 25 6 2022
medline: 30 9 2022
entrez: 24 6 2022
Statut: ppublish

Résumé

Many health care professionals are dealing with the issue of transgender people in their medical practice. In the field of reproduction, Trans people can benefit from fertility preservation before the introduction of hormonal treatment or surgery altering their fertility. This article, which is the result of a collaborative work of several reproductive professionals involved in the health of Trans people, provides an overview of the possibilities of fertility preservation and medically assisted reproduction techniques in France for Trans people.

Identifiants

pubmed: 35750197
pii: S2468-7189(22)00224-0
doi: 10.1016/j.gofs.2022.06.005
pii:
doi:

Types de publication

Guideline Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

682-688

Informations de copyright

Copyright © 2022 Elsevier Masson SAS. All rights reserved.

Auteurs

S Brouillet (S)

Inserm 1203 DEFE, département de biologie de la reproduction, CHU de Montpellier, université de Montpellier, Montpellier, France.

B Ducrocq (B)

CECOS, CHU de Lille, institut de biologie de la reproduction, Lille, France.

S Mestres (S)

Assistance médicale à la procréation, CECOS, CHU de Clermont-Ferrand, CHU d'Estaing, Clermont-Ferrand, France.

C Guillemain (C)

Pôle femmes-parents-enfants, centre clinicobiologique d'assistance médicale à la procréation - CECOS, APHM, hôpital La Conception, 13385 Marseille cedex 5, France.

C Ravel (C)

Inserm, service de biologie de la reproduction - CECOS, EHESP, CHU de Rennes, université Rennes, Irset (institut de recherche en santé, environnement et travail) - UMR_S 1085, 35000 Rennes, France.

A Reignier (A)

Inserm, biologie et médecine de la reproduction et gynécologie médicale, centre de recherche en transplantation et immunologie, UMR 1064, CHU de Nantes, Nantes université, Nantes, France. Electronic address: arnaud.reignier@chu-nantes.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH